ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

EVH vs V // RETURN ON INVESTED CAPITAL (ROIC)

Evolent Health Inc (Class A) (NYSE) VS. Visa Inc. (NYSE) • 15-METRIC TALLY: EVH 1 — V 9
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: V
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EVH VS. V) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC EVH V SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 21.30% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) ACTIVE -26.30% 32.30% -58.60 V /roic <GO>
EV/EBITDA & P/E Valuation — 28.9x — TIE /valuation <GO>
Free Cash Flow Yield 8.08% 2.90% +5.18 EVH /fcf-yield <GO>
Operating Margin -21.90% 60.00% -81.90 V /operating-margins <GO>
Net Profit Margin -30.90% 50.10% -81.00 V /net-margins <GO>
Revenue Growth (YoY) -26.60% 11.30% -37.90 V /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.63% -0.63 V /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 9.09 -8.89 V /balance-sheet <GO>
Piotroski F-Score Quality 4/9 9/9 -5.00 V /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 49.2 65.6 -16.44 V /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.06 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 34.0x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $480.5M $733.53B -$733.05B V /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR EVH REV V REV EVH GROSS % V GROSS % EVH FCF V FCF
FY 2025 $1.88B $40.00B 21.3% — $38.8M $21.26B
FY 2024 $2.55B $35.93B 14.4% — $18.8M $18.33B
FY 2023 $1.96B $32.65B — — $142.6M $19.29B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EVH // BETA —
V // BETA 1.06